The SNMMI said it had been in communication with Humana since November 2020 regarding its denial of coverage of PET/CT and SPECT/CT procedures.
According to the statement, Humana would not provide coverage because the procedures were “experimental/investigational” and “not identified as widely used and generally accepted for the proposed uses as reported in nationally recognized peer-reviewed medical literature.”
The payer also reversed its decision to deny coverage of the imaging procedures when used to identify gastric and esophageal oncologic indications earlier this year.
